Ketamine nasal spray ‘improved severe depression within hours’ in US study
Nasal spray containing component of the party drug reduced suicidal urges in study
A nasal spray containing mind-altering “party drug” ketamine had a fast-acting effect on reducing the symptoms of severe depression, including suicidal thoughts, in a study carried out in the US.
All 68 participants were hospitalised and given antidepressants in the study, carried out by Johnson and Johnson-owned research group Janssen in conjunction with the Yale School of Medicine.
Half the patients also received a nasal spray of esketamine, one of the two molecule components in ketamine, while the others received a placebo.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“In just a matter of hours” participants in the ketamine test group and their doctors “measured a significant improvement in symptoms of patients classed as being at high risk of suicide,” says The Independent.
Although the boost wore off over time - after 25 days, both groups were in a similar condition - the rapid effects of the ketamine spray indicate that it could be particularly beneficial for patients at risk of suicide, especially as most conventional antidepressants take four to six weeks to reach their full effect. Further research is needed before the drug can be approved for use in the US.
Ketamine, a class B drug, is licensed for medical use as an anaesthetic, but in recent years scientists have become increasingly interested in its use in mental health treatment.
Because the drug is already licensed as a medicine for its anaesthetic effects, it is already being prescribed for depression “off label” in private clinics, the BBC reports.
Dr James Stone, from the Royal College of Psychiatrists, told the BBC that the results were "interesting", not least because of the involvement of pharmaceutical giant Johnson and Johnson.
“The main reason for its significance is because this is being developed by a drug company and it's potentially quite likely that this medication might become available as a treatment available on the NHS for depression,” he said.
If approved for use on the NHS, Stone said, the spray “would be aimed at people with severe depression as a second or third line of treatment if other drugs haven't worked”, including as a potential alternative to electroconvulsive therapy.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
'A new era of hurricanes'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
How Britain's demographic is changing
A 50-year record population increase was fuelled by greater migration
By Richard Windsor, The Week UK Published
-
The story of Japanese jeweller Tasaki
The Blend A revival in the use of pearls in fashion and jewellery design places heritage brand Tasaki centre stage
By Felix Bischof Published
-
Putin's fixation with shamans
Under the Radar Secretive Russian leader, said to be fascinated with occult and pagan rituals, allegedly asked for blessing over nuclear weapons
By Harriet Marsden, The Week UK Published
-
A brief history of third parties in the US
In Depth Though none of America's third parties have won a presidential election, they have nonetheless had a large impact on the country's politics
By Joel Mathis, The Week US Published
-
Chimpanzees are dying of human diseases
Under the radar Great apes are vulnerable to human pathogens thanks to genetic similarity, increased contact and no immunity
By Harriet Marsden, The Week UK Published
-
Deaths of Jesse Baird and Luke Davies hang over Sydney's Mardi Gras
The Explainer Police officer, the former partner of TV presenter victim, charged with two counts of murder after turning himself in
By Austin Chen, The Week UK Published
-
Quiz of The Week: 24 February - 1 March
Puzzles and Quizzes Have you been paying attention to The Week's news?
By Sorcha Bradley, The Week UK Published
-
Will mounting discontent affect Iran election?
Today's Big Question Low turnout is expected in poll seen as crucial test for Tehran's leadership
By Sorcha Bradley, The Week UK Published
-
Sweden clears final NATO hurdle with Hungary vote
Speed Read Hungary's parliament overwhelmingly approved Sweden's accession to NATO
By Peter Weber, The Week US Published
-
Modern royal scandals from around the world
The Explainer From Spain to the UAE, royal families have often been besieged by negative events
By Justin Klawans, The Week US Published